Exor Ventures
VC Fund
Amsterdam, The Netherlands
Exor Ventures is a VC fund in Amsterdam focused on Software and Health Care. Exor Ventures is the venture capital arm of Exor, one of Europe's largest diversified holding companies. Exor Ventures focuses on early and growth-stage investments in technology-driven companies across various sectors, including digital services, fintech, cybersecurity, and mobility. Exor Ventures leverages its strategic insights and globalnetwork to identify promising startups with disruptive potential and supports them through funding, mentorship, and access to its extensive resources. EXOR Seeds offers a truly different type of partnership to the select group of entrepreneurs that it backs:- As a fifth-generation family-led business, we proved that we are builders not traders;- Our permanent capital allows us to take a long-term view and put the interest of the companies We invest in first;- Our global network, across industries and geographies, is a unique advantage to entrepreneurs
- Total investments:
- 107
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries Exor Ventures invests in
Stages Exor Ventures invests in
Countries Exor Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $1.8M–$26M
- Pre-Seed
- $320k–$6.3M
- Series A
- $5.8M–$55M
Investment Focus
Industry
- Software 21 (20%)
- Health Care 14 (13%)
- FinTech 12 (11%)
- Artificial Intelligence 12 (11%)
- Information Technology 11 (10%)
Stage
- Seed 29 (27%)
- Pre-Seed 21 (20%)
- Series A 19 (18%)
- Series B 11 (10%)
- Series C 8 (7%)
Country
- United States 26 (24%)
- Italy 23 (21%)
- France 11 (10%)
- United Kingdom 11 (10%)
- Switzerland 3 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Noam Ohana
Managing Director
|
Managing Director | Total investments: 34 | Find email | |
Omry Czapnik
Investor
|
Investor | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Plino
|
Plino is the SMEs FP&A co-pilot, integrating your company data and making it faster and easier to analyse them, empowering entrepreneurs in taking successful informed decisions. On one side it collects, organizes and analyses data from different company’s data sources such as invoices, bank accounts, MES, ERP, WMS, industry 4.0 data, andcompany documents (contracts, technical data sheets). On the other, it provides a user-friendly chat where the user (either the entrepreneur, the CFO, or the accountant) can type questions and receive fast, precise and insightful answers on the company’s revenues, costs, clients, products, and production process. Its mission is to empower SME’s managers to take better informed strategic decisions to lead the company to scale toward success by overcoming market uncertainty. | $764.6K / Pre-Seed / Sep 15, 2025 | |
PhaseV
|
PhaseV is creating tools and cutting-edge statistical approaches to transform trial design, execution, and analysis. PhaseV recognizes hidden signals in clinical data and extracts actionable insights to help determine the best next moves. The company's technology provides optimal adaptive clinical trial design and closed-loop execution,enhancing efficiency and success rates. PhaseV is developing clinical trial paradigm shifts in order to provide novel therapies to more people in a more precise and efficient manner. | $50M / Series A / May 13, 2025 | |
HypeSound
|
Hypesound is revolutionizing the fermentation industry with its innovative sound wave technology. The company is utilizing sonic technology to boost the productivity of algae, yeast, and bacteria, paving the way for sustainable bioproduction and the next industrial revolution. | $1.3M / Pre-Seed / Mar 24, 2025 | |
Byzantine Finance
|
Byzantine is the gateway infrastructure for restaking. We enable anyone to build customizable restaking vaults that give them full control over their risks and rewards. The Byzantine protocol is designed to make risk management of restaking strategies permissionless and flexible allowing for a more competitive, risk-optimised yield. | $3M / Pre-Seed / Feb 25, 2025 | |
N5 Now
|
N5 Now is a create your own digital ecosystem with a platform designed exclusively for the financial industry. | $20M / Series B / Feb 20, 2025 | |
Focoos AI
|
Focoos AI simplifies and accelerates the adoption of artificial vision by offering a platform equipped with ready-to-use neural networks that are easily adaptable to user needs, significantly reducing development time and costs. | $2.8M / Seed / Feb 19, 2025 | |
Almanax
|
Almanax provides AI-powered security tools for web3. | $1M / Venture - Series Unknown / Jan 22, 2025 | |
Tracer Biotechnologies
|
Tracer Biotechnologies is a biotechnology company that offers monitoring services for oncology patients. | $10M / Series A / Dec 12, 2024 | |
Scalestack
|
Scalestack AI brings all of your GTM data together, suggests prioritized actions and helps your reps to execute your sales plays. Unlock a new level of sales productivity and generate more pipeline. | $3M / Seed / Dec 05, 2024 | |
Volta
|
Volta is a developer of software-as-a-service platform focusing on B2B commerce. | $6.3M / Pre-Seed / Nov 25, 2024 | |
| See all 107 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Exor Ventures invest in?
Exor Ventures invests primarily in Software, Health Care and FinTech startups, most often at Seed and Pre-Seed stage. Most of the 107 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Exor Ventures's check size?
Exor Ventures typically joins rounds of $1.8M–$26M at Seed, $320k–$6.3M at Pre-Seed and $5.8M–$55M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Exor Ventures participates in.
How do I contact Exor Ventures?
Public channels for Exor Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Exor Ventures?
The team at Exor Ventures includes Noam Ohana (Managing Director) and Omry Czapnik (Investor). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
